Provided by Tiger Trade Technology Pte. Ltd.

MABWELL-B

21.940
-0.140-0.63%
Volume:153.40K
Turnover:3.35M
Market Cap:9.81B
PE:-7.74
High:22.640
Open:22.640
Low:21.480
Close:22.080
52wk High:31.460
52wk Low:20.160
Shares:447.00M
HK Float Shares:47.13M
Volume Ratio:0.43
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-2.836
ROE:-118.88%
ROA:-11.80%
PB:78.68
PE(LYR):-7.74
PS:11.28

Loading ...

Mabwell Sets 30 August Board Meeting to Approve 1H 2026 Interim Results

Bulletin Express
·
Aug 19

Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge

Stock News
·
Aug 11

MABWELL-B Surges Over 13% in Morning Trade After Two Denosumab Injections Pass Brazilian Regulator GMP Inspection

Deep News
·
Aug 11

Mabwell (688062.SH) Receives NMPA Approval for 9MW5211 Injection Clinical Trial Application

Stock News
·
Jul 31

Mabwell Bio Gets China Clinical Trial Approval for Vitiligo Drug

MT Newswires Live
·
Jul 16

Mabwell secures NMPA clearance to begin clinical trials of 9MW5211 for vitiligo

Bulletin Express
·
Jul 15

Mabwell Bioscience Gets China Nod for Diabetes Mellitus Drug Candidate Trial

MT Newswires Live
·
Jul 08

Mabwell Receives Regulatory Clearance for Clinical Trial of 9MW5211 Injection Targeting Type 1 Diabetes

Stock News
·
Jul 07

Mabwell Reports No Change in Share Capital or Share Count for June 2026; Public Float Fully Compliant

Bulletin Express
·
Jul 07

Mabwell gains NMPA approval for 9MW5211 multiple-sclerosis trial; IBD programme cleared in China and U.S.

Bulletin Express
·
Jun 24

Mabwell Gets China Nod for Hematological Malignancy Drug Trial

MT Newswires Live
·
Jun 24

Mabwell Bioscience Receives Regulatory Clearance to Initiate Human Trials for Investigational Drug 6MW5311

Stock News
·
Jun 23

Key Developments for Hong Kong Stocks: New Policy to Boost AI in Consumption and Strait Closure

Stock News
·
Jun 22

Mabwell Highlights Promising Survival and Response Data for Nectin-4 ADC 9MW2821 in Cervical Cancer at ESMO Gynae 2026

Bulletin Express
·
Jun 18

MABWELL-B to Present Latest Clinical Data for 9MW2821 at 2026 ESMO Gynaecological Cancers Congress

Stock News
·
Jun 18

MABWELL-B Announces Change in Authorized Representative

Stock News
·
Jun 18

Mabwell appoints Executive Director Hua Jun as new authorised representative

Bulletin Express
·
Jun 18

Mabwell Announces Updated Board Composition and Committee Appointments

Bulletin Express
·
Jun 18

MABWELL-B Appoints Dr. Gui Xun as Employee Representative Director

Stock News
·
Jun 18

Mabwell Bioscience Clears All Agenda Items at 2026 Third EGM; Approves EY as Auditor and New H-Share Issuance Mandate

Bulletin Express
·
Jun 18